VC  Venture Investors

     Office Locations:

201 South Main Street, Suite 900
Ann Arbor, MI 48104
Phone: 734-274-2904
Fax: 734-214-3006

Get all office locations for this firm with a National Database subscription.


  • Early
  • Seed



  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device



    Since 1982, Venture Investors has been providing seed and early stage venture capital to technology based companies in the Midwest. The firm focuses on Healthcare (including Biotechnology and Medical Devices), Clean Tech, and Information Technology. Venture Investors is currently investing out of its fifth fund and has over $200 million under management. Venture Investors considers seed rounds starting at $250,000 up to $8.0M over time. The firm has backed 19 companies that have been founded to commercialize innovations licensed from leading research institutions throughout the Midwest.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Becky Hoerman Controller
    David Arnstein CFO
    Jim Adox Managing Director
    John Neis Executive Managing Director
    Paul Weiss Managing Director


    Recent Funding Events (trailing 12 months):







      Iterion Therapeutics



      Series B


    Portfolio companies include:

      Aerpio Therapeutics
        web link

        web link

      Akebia Therapeutics
        web link

      Eximis Surgical
        web link

        web link

      Health Scholars
        web link

        web link

        web link



      Iterion Therapeutics
        web link

      Juventas Therapeutics
        web link

      Madison Vaccines
        web link

        web link

        web link

      NeuWave Medical
        web link


      Reshape Medical
        web link

        web link

      TAI Diagnostics


    Recent News: